And for some people, they are significant enough to reconsider whether this supplement belongs in their routine at all
How often it happens The rates vary by trial and population: 2,3 TRIUMPH-4 (obesity with knee osteoarthritis): 8.8% on 9 mg, 20.9% on 12 mg, 0.7% on placebo TRANSCEND-T2D-1 (type 2 diabetes): 4.5% on 4 mg, 2.3% on 9 mg, 4.4% on 12 mg, 0% on placebo Phase 2 trial (Jastreboff 2023): not reported The TRIUMPH-4 numbers are markedly higher than those of TRANSCEND-T2D-1
Biochem J (2007) 403(1):13948
Stronger satiety signals are sent, which naturally reduces meal portionswithout feelings of deprivation
FDA expressly stated that compounding, regularly or in inordinate amounts, a drug product that is essentially a copy of a commercially available drug product is impermissible